Comment on: “Cell therapy for heart disease: Trial sequential analyses of two cochrane reviews”

Author:

Castellini G123,Nielsen EE3,Gluud C3

Affiliation:

1. Department of Biomedical Sciences for Health; University of Milan; Milan Italy

2. Unit of Clinical Epidemiology; I.R.C.C.S. Orthopedic Institute Galeazzi; Milan Italy

3. The Copenhagen Trial Unit; Centre for Clinical Intervention Research; Copenhagen Denmark

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference10 articles.

1. Thorlund , K. Engstrøm , J. Wetterslev , J. Brok , J. Imberger , G. Gluud , C. User manual for Trial Sequential Analysis (TSA) 2011 1 115 www.ctu.dk/tsa

2. Cell therapy for heart disease: trial sequential analyses of two Cochrane reviews;Fisher;Clin. Pharmacol. Ther.,2016

3. Clinical effectiveness and cost-effectiveness of immediate angioplasty for acute myocardial infarction: systematic review and economic evaluation;Hartwell;Health Technol. Assess.,2005

4. Why most published research findings are false;Ioannidis;PLoS Med.,2005

5. Attention should be given to multiplicity issues in systematic reviews;Bender;J. Clin. Epidemiol.,2008

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3